Elequin Capital’s PLDT PHI Stock Holding History

Elequin Capital’s Portfolio PHI Stock Details PHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$929	Buy	53 +36	+212%	+$697	﹤0.01%	579
2026 Q1	$358	Buy	+17	New	+$384	﹤0.01%	587

Other funds holding PHI

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Elequin Capital's PHI Position: Q2 2026 in Review

Elequin Capital increased its PLDT (PHI) stake by 212% in Q2 2026, buying an estimated $697 and bringing the position to 53 shares worth $929. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Elequin Capital first reported a position in PHI in Q1 2026 and has held it in 2 quarters since. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

Elequin Capital held 53 shares of PLDT worth $929 as of Q2 2026.
Elequin Capital bought 36 PLDT shares in Q2 2026, an estimated $697.
PLDT made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #579 holding.
Elequin Capital first reported a position in PLDT in Q1 2026 and has held it in 2 quarters since.
100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.